SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Mar 12, 2021
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2020-07-01$0.98/sh+5,000$4,900→ 37,500 total - Award
Stock Option (right to buy)
2021-03-10+200,000→ 200,000 totalExercise: $3.30Exp: 2031-03-10→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
- [F2]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates. The stock option is also subject to stockholder approval of an increase in the share reserve under the Company's 2017 Equity Incentive Plan, which approval must occur within one year from the grant date